VivoSeq
Other

Mitochondria

0

Pipeline Programs

4

Active Trials

2

Companies Involved

Mitochondria is an early-stage landscape with 0 programs across 2 companies. The most active players are Minovia Therapeutics Ltd., PTC Therapeutics.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

14/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

21

clinical trials

Completed12 · 57%
Recruiting3 · 14%
Terminated2 · 10%
Not yet recruiting1 · 5%
Unknown status1 · 5%
No longer available1 · 5%
Other1 · 5%

Trial Activity

21 trials

Mitochondrial Function After Ketamine
Not yet recruiting·SSheba Medical Center·N/A·NCT07399756·30 enrolled
Mitochondrial Function in Septic Patients
Completed··N/A·NCT03748537·20 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)